|Articles|April 15, 2003
- BioPharm International-04-01-2003
- Volume 16
- Issue 4
GMP Issues: Breaking Ground
Author(s)Paula J. Shadle, PhD
by Paula Shadle, Shadle Consulting When building a biotech manufacturing facility and a QC lab, which scenario do you choose ? build manufacturing first, build the QC lab first, or build both facilities simultaneously?
Advertisement
Articles in this issue
almost 23 years ago
Virus Inactivation in the 1990s and into the 21st Centuryalmost 23 years ago
Getting Ready for Risk-Based GMPsalmost 23 years ago
Guest Editorial: Benchmarking Biotechalmost 23 years ago
Optimized Nutrient Additives for Fed-Batch Culturesalmost 23 years ago
Inside Washington: GMP Progress ReportNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
